8-Oct-2026 - Fintel Barclays initiates coverage of Edwards Lifesciences with overweight rating Fintel reports that on October 7, 2026, Barclays initiated coverage of Edwards Lifesciences (BMV:EW) with a Overweight recommendation. This action follows a prior action by Barclays on April 27, 2026, ...
6-Oct-2026 - Fintel Barclays initiates coverage of Edwards Lifesciences at overweight Fintel reports that on 7 October 2026, Barclays initiated coverage of Edwards Lifesciences (SWX:EW) with a Overweight recommendation. This rating action follows a prior action by Barclays on 27 April ...
16-Sep-2026 - Yahoo Finance Edwards Lifesciences Sees TAVR Expansion, $2B TMTT Opportunity Ahead Edwards Lifesciences (NYSE:EW) outlined a strategy centered on structural heart disease, with Chief Executive Officer Bernard Zovighian highlighting five therapy areas that the company views as its ...
10-Sep-2026 - The Globe and Mail Edwards Lifesciences (EW) Gets a Buy from Citi Citi analyst Joanne Wuensch maintained a Buy rating on Edwards Lifesciences today and set a price target of $110.00. Wuensch covers the Healthcare sector, focusing on stocks such as Abbott ...
4-Sep-2026 - Yahoo Finance Edwards Lifesciences Corporatio EW Stock Forecast & Price Target At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Latest EW Trades by Congress Members
19-NOV-2025 - Josh Gottheimer, NJ (District 5) sold between $1,001 and $15,000.
8-Oct-2026 - Fintel Barclays initiates coverage of Edwards Lifesciences with overweight rating Fintel reports that on October 7, 2026, Barclays initiated coverage of Edwards Lifesciences (BMV:EW) with a Overweight recommendation. This action follows a prior action by Barclays on April 27, 2026, ...
6-Oct-2026 - Fintel Barclays initiates coverage of Edwards Lifesciences at overweight Fintel reports that on 7 October 2026, Barclays initiated coverage of Edwards Lifesciences (SWX:EW) with a Overweight recommendation. This rating action follows a prior action by Barclays on 27 April ...
16-Sep-2026 - Yahoo Finance Edwards Lifesciences Sees TAVR Expansion, $2B TMTT Opportunity Ahead Edwards Lifesciences (NYSE:EW) outlined a strategy centered on structural heart disease, with Chief Executive Officer Bernard Zovighian highlighting five therapy areas that the company views as its ...
10-Sep-2026 - The Globe and Mail Edwards Lifesciences (EW) Gets a Buy from Citi Citi analyst Joanne Wuensch maintained a Buy rating on Edwards Lifesciences today and set a price target of $110.00. Wuensch covers the Healthcare sector, focusing on stocks such as Abbott ...
4-Sep-2026 - Yahoo Finance Edwards Lifesciences Corporatio EW Stock Forecast & Price Target At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
